UAB Uniqmed Pharma Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 928,671 |
| 530,669 |
| 72,026 |
| 61,222 |
| 34,984 |
| 21.39 |
| 6.59 |
| 322,290 |
| 369,598 |
| 0 |
| 691,888 |
| 2023 |
|---|
| 121,048 |
| 63,376 |
| -48,620 |
| -48,620 |
| -25,455 |
| 24.08 |
| -40.17 |
| 273,670 |
| 244,322 |
| 0 |
| 517,992 |
| 2024 |
|---|
| 11,655 |
| 5,828 |
| 31,336 |
| -31,336 |
| -15,668 |
| -89.42 |
| -268.86 |
| 242,334 |
| 328,806 |
| 341,992 |
| 229,148 |
Register and
explore Okredo data| 2024 |
|---|
| 11,655 |
| 5,828 |
| 31,336 |
| -31,336 |
| -15,668 |
| -89.42 |
| -268.86 |
| 242,334 |
| 328,806 |
| 341,992 |
| 229,148 |
Register and
explore Okredo data2024
Turnover (€)
11,655 €
-90 % *
Sales per employee (€)
5,828 €-91 % *
Profit before tax (€)
31,336 €
164 % *
Net Profit (€)
-31,336 €36 % *
Profit per employee (€)
-15,668 €38 % *
Total profitability (%)
-89.42 %-471.35 % *
Net profitability (%)
-268.86 %-569.31 % *
Equity (€)
242,334 €-11 % *
Amounts Payable And Liabilities (€)
328,806 €
35 % *
Non-current Assets (€)
341,992 €
- *
CurrentAssets (€)
229,148 €
-56 % *